Characterizing cannabis-induced psychosis: A study with prepulse inhibition of the startle reflex

Psychiatry Research

Volumn 220, Issue 1-2, 2014, Pages 535-540

  Morales Muñoz, Isabel ^a,c   Jurado Barba, Rosa ^a,b,c   Ponce, Guillermo ^a,b,c   Martínez Gras, Isabel ^a,b,c   Ángel Jiménez Arriero, Miguel ^a,b,c   Moratti, Stephan ^c   Rubio, Gabriel ^a,c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cannabis; Cannabis induced psychotic disorder; Prepulse inhibition; Schizophrenia

Indexed keywords

OLANZAPINE; RISPERIDONE; CANNABIS;

ADULT; ARTICLE; ATTENTION DISTURBANCE; CANNABIS ADDICTION; CANNABIS INDUCED PSYCHOSIS; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREPULSE INHIBITION; PSYCHOPHYSIOLOGY; PSYCHOSIS; SCHIZOPHRENIA; STARTLE REFLEX; ATTENTION; COMPLICATION; PHYSIOLOGY; PSYCHOLOGY; YOUNG ADULT;

ADULT; ATTENTION; CANNABIS; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; PREPULSE INHIBITION; PSYCHOSES, SUBSTANCE-INDUCED; REFLEX, STARTLE; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84908151689     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.08.010     Document Type: Article

References (41)

1. APA Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatry Press, Washington, DC. fourth edition.
2. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978, 15:339-343.
3. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Archives of General Psychiatry 1990, 47:181-188.
4. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Archives of General Psychiatry 1992, 49:206-215.
5. Braff D.L., Freedman R., Schork N.J., Gottesman I.I. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophrenia Bulletin 2007, 33:21-32.
6. Broyd S.J., Greenwood L.M., Croft R.J., Dalecki A., Todd J., Michie P.T., Johnstone S.J., Solowij N. Chronic effects of cannabis on sensory gating. International Journal of Psychophysiology 2013, 89:381-389.
7. Cadenhead K.S., Swerdlow N.R., Shafer K.M., Diaz M., Braff D.L. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. The American Journal of Psychiatry 2000, 157:1660-1668.
8. Caton C.L., Drake R.E., Hasin D.S., Dominguez B., Shrout P.E., Samet S., Schanzer B. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Archives of General Psychiatry 2005, 62:137-145.
9. D'Souza D.C. Cannabinoids and psychosis. International Review of Neurobiology 2007, 78:289-326.
10. D'Souza D.C., Perry E., MacDougall L., Ammerman Y., Cooper T., Wu Y.T., Braley G., Gueorquieva R., Krystal J.H. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 2009, 29:1558-1572.
11. Dawe S., Geppert L., Occhipinti S., Kingswell W. A comparison of the symptoms and short-term clinical course in inpatients with substance-induced psychosis and primary psychosis. Journal of Substance Abuse Treatment 2011, 40:95-101.
12. Dawson M., Hazlett E., Filion D., Nuechterlein K., Schell A. Attention and schizophrenia: impaired modulation of the startle reflex. Journal of Abnormal Psychology 1993, 102:633-641.
13. Duley A.R., Hillman C.H., Coombes S., Janelle C.M. Sensorimotor gating and anxiety: prepulse inhibition following acute exercise. International Journal of Psychophysiology 2007, 64:157-164.
14. Flaten M.A., Nordmark E., Elden A. Effects of background noise on the human startle reflex and prepulse inhibition. Psychophysiology 2005, 42:298-305.
15. Fried P.A., Watkinson B., Gray R. Neurocognitive consequences of marihuana-a comparison with pre-drug performance. Neurotoxicology and Teratology 2005, 27:231-239.
16. Grillon C., Ameli R., Charney D.S., Krystal J., Braff D. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biological Psychiatry 1992, 32:939-943.
17. Hasin D.S., Trautman K.D., Miele G.M., Samet S., Smith M., Endicott J. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. The American Journal of Psychiatry 1996, 153:1195-1201.
18. Imade A.G., Ebie J.C. A retrospective study of symptom patterns of cannabis-induced psychosis. Acta Psychiatrica Scandinavica 1991, 83:134-136.
19. Jurado-Barba R., Morales-Muñoz I., Álvarez B.A., Fernández-Guinea S., Caballero M., Martínez-Gras I., Rubio-Valladolid G. Relationship between measures of inhibitory processes in patients with schizophrenia: role of substance abuse disorders. Psychiatry Research 2011, 190:187-192.
20. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. The American Journal of Psychiatry 2003, 160:13-23.
21. Kay S.R., Opler L.A., Fiszbein A. The Positive and Negative Syndrome Scale Manual 1992, Multi-Health Systems, Inc., Toronto.
22. Kedzior K.K., Martin-Iverson M.T. Chronic cannabis use is associated with attention-modulated reduction in prepulse inhibition of the startle reflex in healthy humans. Journal of Psychopharmacology 2006, 20:471-484.
23. Ludewig S., Ludewig K., Geyer M.A., Hell D., Vollenweider F.X. Prepulse inhibition deficits in patients with panic disorder. Depression and Anxiety 2002, 15:55-60.
24. Martin R.S., Secchi R.L., Sung E., Lemaire M., Bonhaus D.W., Hedley L.R., Lowe D.A. Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat. Psychopharmacology 2003, 165:128-135.
25. Martinez-Gras I., Rubio G., del Manzano B., Rodriguez-Jimenez R., Garcia-Sanchez F., Bagney A., Borrell J. The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone. Schizophrenia Research 2009, 115:215-221.
26. Mayer A.R., Hanlon F.M., Franco A.R., Toshiba T.M., Thoma R.J., Clark V.P., Canive J.M. The neural networks underlying auditory sensory gating. Neuroimage 2009, 44:182-189.
27. Nuñez L.A., Gurpegui M. Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia. Acta Psychiatrica Scandinavica 2002, 105:173-178.
28. Oleson E.B., Cheer J.F. A brain on cannabinoids: the role of dopamine release in reward seeking. Cold Spring Harbor Perspectives in Medicine 2012, 2:8-15.
29. Quednow B.B., Kuhn K.U., Hoenig K., Maier W., Wagner M. Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls. Neuropsychopharmacology 2004, 29:982-990.
30. Rubio G., Marin-Lozano J., Ferre F., Martinez-Gras I., Rodriguez-Jimenez R., Sanz J., Jiménez-Arriero M.A., Carrasco J.L., Lora D., Jurado R., López-Trabada J.R., Palomo T. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis. Comprehensive Psychiatry 2012, 53:1063-1070.
31. Scholes-Balog K.E., Martin-Iverson M.T. Cannabis use and sensorimotor gating in patients with schizophrenia and healthy controls. Human Psychopharmacology 2011, 26:373-385.
32. Scholes K.E., Martin-Iverson M.T. Alterations to pre-pulse inhibition (PPI) in chronic cannabis users are secondary to sustained attention deficits. Psychopharmacology 2009, 207:469-484.
33. Sewell R.A., Ranganathan M., D'Souza D.C. Cannabinoids and psychosis. International Review of Psychiatry 2009, 21:152-162.
34. Spiga S., Lintas A., Migliore M., Diana M. Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependence. Addiction Biology 2010, 15:266-276.
35. Swerdlow N.R., Benbow C.H., Zisook S., Geyer M.A., Braff D.L. A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biological Psychiatry 1993, 33:298-301.
36. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Archives of General Psychiatry 1994, 51:139-154.
37. Swerdlow N.R., Filion D., Geyer M.A., Braff D.L. "Normal" personality correlates of sensorimotor, cognitive, and visuospatial gating. Biological Psychiatry 1995, 37:286-299.
38. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 2001, 156:194-215.
39. Thomas H. Psychiatric symptoms in cannabis users. The British Journal of Psychiatry 1993, 163:141-149.
40. Torrens M., Serrano D., Astals M., Perez-Dominguez G., Martin-Santos R. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. The American Journal of Psychiatry 2004, 161:1231-1237.
41. Wan F.J., Taaid N., Swerdlow N.R. Do D1/D2 interactions regulate prepulse inhibition in rats?. Neuropsychopharmacology 1996, 14:265-274.